Cargando…

Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes

BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanzad, Maryam, Tashayoie-Nejad, Sabereh, Boloursaz, Mohammadreza, Mahdaviani, Seyed Alireza, Baghaie, Nooshin, Ghaffaripour, Hosseinali, Aghahosseini, Farahnaz, Hossein Ahmadi, Zargham, Parsa, Tahereh, Farzanegan, Behrooz, Fakharian, Atefeh, Seyedi, Seyed Javad, Velayati, Ali Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577214/
https://www.ncbi.nlm.nih.gov/pubmed/36267924
_version_ 1784811709215539200
author Hassanzad, Maryam
Tashayoie-Nejad, Sabereh
Boloursaz, Mohammadreza
Mahdaviani, Seyed Alireza
Baghaie, Nooshin
Ghaffaripour, Hosseinali
Aghahosseini, Farahnaz
Hossein Ahmadi, Zargham
Parsa, Tahereh
Farzanegan, Behrooz
Fakharian, Atefeh
Seyedi, Seyed Javad
Velayati, Ali Akbar
author_facet Hassanzad, Maryam
Tashayoie-Nejad, Sabereh
Boloursaz, Mohammadreza
Mahdaviani, Seyed Alireza
Baghaie, Nooshin
Ghaffaripour, Hosseinali
Aghahosseini, Farahnaz
Hossein Ahmadi, Zargham
Parsa, Tahereh
Farzanegan, Behrooz
Fakharian, Atefeh
Seyedi, Seyed Javad
Velayati, Ali Akbar
author_sort Hassanzad, Maryam
collection PubMed
description BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific criteria for lavage, but in case of observing these signs it is recommended to perform lavage for the patient: progressive respiratory failure, no labored breathing at rest, and drop in oxygen level during activity (>5%). MATERIALS AND METHODS: In this study, patients with PAP admitted to Pediatric ward of Masih Daneshvari Hospital were studied. The required data were collected including the patient's demographic data, clinical signs and radiographic data, the number of admissions, the age of diagnosis, detection and treatment methods, number of lavage, current condition of the patient, and in case of death, the cause of death. RESULTS: In this study, 17 patients with PAP who were admitted during the past 15 years were examined; among which 7 patients were boys (41.2%) and 10 were girls (58.8%). The mean age of population was 11.79±7.21 years. Transbronchial Lung Biopsy (TBLB) (47.1%) and open lung biopsy (52.9%) were used for diagnosis of patients. Lung lavage was used to treat patients, 15 of whom were treated by this method. Five of the patients died because of their serious conditions. CONCLUSION: Therapy method in the present study was lavage for both lungs, and it was performed for all patients except for two patients due to their anatomical complications. This method is still considered as the gold standard for PAP. Considering the findings from previous studies and the present study, it seems that Whole Lung Lavage (WLL) was fruitful for patients who had the indication for using this therapy and it played a significant role in improving the prognosis of patients. Besides, it is recommended to do follow-up regularly in order to have more therapeutic efficacy and increased patient longevity.
format Online
Article
Text
id pubmed-9577214
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-95772142022-10-19 Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes Hassanzad, Maryam Tashayoie-Nejad, Sabereh Boloursaz, Mohammadreza Mahdaviani, Seyed Alireza Baghaie, Nooshin Ghaffaripour, Hosseinali Aghahosseini, Farahnaz Hossein Ahmadi, Zargham Parsa, Tahereh Farzanegan, Behrooz Fakharian, Atefeh Seyedi, Seyed Javad Velayati, Ali Akbar Tanaffos Original Article BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific criteria for lavage, but in case of observing these signs it is recommended to perform lavage for the patient: progressive respiratory failure, no labored breathing at rest, and drop in oxygen level during activity (>5%). MATERIALS AND METHODS: In this study, patients with PAP admitted to Pediatric ward of Masih Daneshvari Hospital were studied. The required data were collected including the patient's demographic data, clinical signs and radiographic data, the number of admissions, the age of diagnosis, detection and treatment methods, number of lavage, current condition of the patient, and in case of death, the cause of death. RESULTS: In this study, 17 patients with PAP who were admitted during the past 15 years were examined; among which 7 patients were boys (41.2%) and 10 were girls (58.8%). The mean age of population was 11.79±7.21 years. Transbronchial Lung Biopsy (TBLB) (47.1%) and open lung biopsy (52.9%) were used for diagnosis of patients. Lung lavage was used to treat patients, 15 of whom were treated by this method. Five of the patients died because of their serious conditions. CONCLUSION: Therapy method in the present study was lavage for both lungs, and it was performed for all patients except for two patients due to their anatomical complications. This method is still considered as the gold standard for PAP. Considering the findings from previous studies and the present study, it seems that Whole Lung Lavage (WLL) was fruitful for patients who had the indication for using this therapy and it played a significant role in improving the prognosis of patients. Besides, it is recommended to do follow-up regularly in order to have more therapeutic efficacy and increased patient longevity. National Research Institute of Tuberculosis and Lung Disease 2021-04 /pmc/articles/PMC9577214/ /pubmed/36267924 Text en Copyright© 2021 National Research Institute of Tuberculosis and Lung Disease https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Hassanzad, Maryam
Tashayoie-Nejad, Sabereh
Boloursaz, Mohammadreza
Mahdaviani, Seyed Alireza
Baghaie, Nooshin
Ghaffaripour, Hosseinali
Aghahosseini, Farahnaz
Hossein Ahmadi, Zargham
Parsa, Tahereh
Farzanegan, Behrooz
Fakharian, Atefeh
Seyedi, Seyed Javad
Velayati, Ali Akbar
Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title_full Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title_fullStr Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title_full_unstemmed Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title_short Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
title_sort pulmonary alveolar proteinosis in children: diagnosis and treatment outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577214/
https://www.ncbi.nlm.nih.gov/pubmed/36267924
work_keys_str_mv AT hassanzadmaryam pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT tashayoienejadsabereh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT boloursazmohammadreza pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT mahdavianiseyedalireza pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT baghaienooshin pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT ghaffaripourhosseinali pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT aghahosseinifarahnaz pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT hosseinahmadizargham pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT parsatahereh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT farzaneganbehrooz pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT fakharianatefeh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT seyediseyedjavad pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes
AT velayatialiakbar pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes